Metabolic Inflexibility is Related to Elevated Muscle Anaerobic Glycolysis

Description

The focus of this proposal is on overweight (25\>BMI\<30 kg/m2) subjects, as these individuals exhibit a high risk of becoming obese and/or developing metabolic diseases. We hypothesize that in some overweight individuals there is a "metabolic program" in skeletal muscle which predisposes them to the development of obesity. Findings may lead to clinical screening tools for determining risk for obesity in non-obese individuals and targeting this group for prevention.

Conditions

Metabolic Inflexibility

Study Overview

Study Details

Study overview

The focus of this proposal is on overweight (25\>BMI\<30 kg/m2) subjects, as these individuals exhibit a high risk of becoming obese and/or developing metabolic diseases. We hypothesize that in some overweight individuals there is a "metabolic program" in skeletal muscle which predisposes them to the development of obesity. Findings may lead to clinical screening tools for determining risk for obesity in non-obese individuals and targeting this group for prevention.

Metabolic Inflexibility is Related to Elevated Muscle Anaerobic Glycolysis

Metabolic Inflexibility is Related to Elevated Muscle Anaerobic Glycolysis

Condition
Metabolic Inflexibility
Intervention / Treatment

-

Contacts and Locations

Greenville

East Carolina University, Greenville, North Carolina, United States, 27834

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18-50 years old
  • * BMI of 25 - 30 kg/m2
  • * BMI \> 40kg/m2
  • * Lactate levels in top and lower 25%
  • * Pregnant women
  • * Mentally disabled
  • * Prisoners
  • * Smokers
  • * Subjects with heart disease
  • * Type 1 and 2 diabetes
  • * Endocrine disease
  • * Hypertension
  • * Musculoskeletal disease
  • * Peripheral occlusion
  • * Hepatic disease
  • * Have had weight fluctuations exceeding + 3% in the previous 12 months
  • * On medications which alter carbohydrate metabolism will not be studied

Ages Eligible for Study

18 Years to 50 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

East Carolina University,

Joseph Houmard, PhD, PRINCIPAL_INVESTIGATOR, East Carolina University

Study Record Dates

2024-12